Changmao Biochemical Engineering Co (HKSE:00954) Total Stockholders Equity : HK$811.5 Mil (As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Changmao Biochemical Engineering Co Total Stockholders Equity?

Changmao Biochemical Engineering Co's Total Stockholders Equity for the quarter that ended in Jun. 2023 was HK$811.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Changmao Biochemical Engineering Co's Book Value per Share for the quarter that ended in Jun. 2023 was HK$1.53. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Changmao Biochemical Engineering Co's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.56.

Changmao Biochemical Engineering Co Total Stockholders Equity Historical Data

The historical data trend for Changmao Biochemical Engineering Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Total Stockholders Equity Chart

Changmao Biochemical Engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

736.30

769.79

853.58

869.40

712.80

Changmao Biochemical Engineering Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															853.58	865.06	869.40	811.48	712.80

Changmao Biochemical Engineering Co (HKSE:00954) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Changmao Biochemical Engineering Co's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(811.48	-	0)	/	529.7
	=	1.53

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Changmao Biochemical Engineering Co's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(305.968	+	148.227)	/	811.48
	=	0.56

Changmao Biochemical Engineering Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Changmao Biochemical Engineering Co (HKSE:00954) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034

Website

http://www.cmbec.com.hk

Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.

Changmao Biochemical Engineering Co (HKSE:00954) Headlines

No Headlines